| Dexamethasone | Approved Investigational Vet Approved | MX2 | 4600 |
upregulated | Dexamethasone results in increased expression of MX2 mRNA | 21q22.3 | |
| Dexamethasone | Approved Investigational Vet Approved | MXI1 | 4601 |
downregulated | Dexamethasone results in decreased expression of MXI1 mRNA | 10q25.2 | |
| Dexamethasone | Approved Investigational Vet Approved | MYB | 4602 |
upregulated | Dexamethasone results in increased expression of MYB mRNA | 6q23.3 | |
| Dexamethasone | Approved Investigational Vet Approved | MYC | 4609 |
downregulated | Dexamethasone results in decreased expression of MYC mRNA | 8q24.21 | |
| Dexamethasone | Approved Investigational Vet Approved | MYC | 4609 |
upregulated | Dexamethasone results in increased expression of MYC mRNA | 8q24.21 | |
| Dexamethasone | Approved Investigational Vet Approved | MYCBP2 | 23077 |
upregulated | Dexamethasone results in increased expression of MYCBP2 mRNA | 13q22.3 | |
| Dexamethasone | Approved Investigational Vet Approved | MYL6B | 140465 |
downregulated | Dexamethasone results in decreased expression of MYL6B mRNA | 12q13.2 | |
| Dexamethasone | Approved Investigational Vet Approved | MYLK | 4638 |
upregulated | Dexamethasone results in increased expression of MYLK mRNA | 3q21.1 | |
| Dexamethasone | Approved Investigational Vet Approved | N4BP2L2 | 10443 |
downregulated | Dexamethasone results in decreased expression of N4BP2L2 mRNA | 13q13.1 | |
| Dexamethasone | Approved Investigational Vet Approved | NAA50 | 80218 |
upregulated | Dexamethasone results in increased expression of NAA50 mRNA | 3q13.31 | |
| Dexamethasone | Approved Investigational Vet Approved | NAB2 | 4665 |
downregulated | Dexamethasone results in decreased expression of NAB2 mRNA | 12q13.3 | |
| Dexamethasone | Approved Investigational Vet Approved | NABP1 | 64859 |
upregulated | Dexamethasone results in increased expression of NABP1 mRNA | 2q32.3 | |
| Dexamethasone | Approved Investigational Vet Approved | NAMPT | 10135 |
downregulated | Dexamethasone results in decreased expression of NAMPT mRNA | 7q22.3 | |
| Dexamethasone | Approved Investigational Vet Approved | NAMPT | 10135 |
upregulated | Dexamethasone results in increased expression of NAMPT mRNA | 7q22.3 | |
| Dexamethasone | Approved Investigational Vet Approved | NANOS1 | 340719 |
upregulated | Dexamethasone results in increased expression of NANOS1 mRNA | 10q26.11 | |
| Dexamethasone | Approved Investigational Vet Approved | NAV1 | 89796 |
downregulated | Dexamethasone results in decreased expression of NAV1 mRNA | 1q32.1 | |
| Dexamethasone | Approved Investigational Vet Approved | NAV3 | 89795 |
upregulated | Dexamethasone results in increased expression of NAV3 mRNA | 12q21.2 | |
| Dexamethasone | Approved Investigational Vet Approved | NBEAL2 | 23218 |
upregulated | Dexamethasone results in increased expression of NBEAL2 mRNA | 3p21.31 | |
| Dexamethasone | Approved Investigational Vet Approved | NCOA1 | 8648 |
upregulated | Dexamethasone results in increased expression of NCOA1 mRNA | 2p23.3 | |
| Dexamethasone | Approved Investigational Vet Approved | NCOA2 | 10499 |
upregulated | Dexamethasone results in increased expression of NCOA2 mRNA | 8q13.3 | |
| Dexamethasone | Approved Investigational Vet Approved | NDRG2 | 57447 |
upregulated | Dexamethasone results in increased expression of NDRG2 mRNA | 14q11.2 | |
| Dexamethasone | Approved Investigational Vet Approved | NDUFA4L2 | 56901 |
downregulated | Dexamethasone results in decreased expression of NDUFA4L2 mRNA | 12q13.3 | |
| Dexamethasone | Approved Investigational Vet Approved | NEFL | 4747 |
upregulated | Dexamethasone results in increased expression of NEFL mRNA | 8p21.2 | |
| Dexamethasone | Approved Investigational Vet Approved | NELFA | 7469 |
upregulated | Dexamethasone results in increased expression of NELFA mRNA | 4p16.3 | |
| Dexamethasone | Approved Investigational Vet Approved | NEUROG1 | 4762 |
downregulated | Dexamethasone results in decreased expression of NEUROG1 mRNA | 5q31.1 | |